| GO:0006259 | DNA metabolic process | 27.27% (39/143) | 3.33 | 0.0 | 0.0 |
| GO:0006260 | DNA replication | 15.38% (22/143) | 4.03 | 0.0 | 0.0 |
| GO:0090304 | nucleic acid metabolic process | 30.77% (44/143) | 2.09 | 0.0 | 0.0 |
| GO:0051726 | regulation of cell cycle | 12.59% (18/143) | 3.58 | 0.0 | 0.0 |
| GO:0006261 | DNA-dependent DNA replication | 11.19% (16/143) | 3.92 | 0.0 | 0.0 |
| GO:0006479 | protein methylation | 11.89% (17/143) | 3.51 | 0.0 | 0.0 |
| GO:0008213 | protein alkylation | 11.89% (17/143) | 3.51 | 0.0 | 0.0 |
| GO:0006139 | nucleobase-containing compound metabolic process | 31.47% (45/143) | 1.73 | 0.0 | 0.0 |
| GO:0016569 | covalent chromatin modification | 13.29% (19/143) | 3.2 | 0.0 | 0.0 |
| GO:0016570 | histone modification | 12.59% (18/143) | 3.31 | 0.0 | 0.0 |
| GO:0016458 | gene silencing | 11.89% (17/143) | 3.43 | 0.0 | 0.0 |
| GO:0051567 | histone H3-K9 methylation | 9.79% (14/143) | 3.92 | 0.0 | 0.0 |
| GO:0061647 | histone H3-K9 modification | 9.79% (14/143) | 3.92 | 0.0 | 0.0 |
| GO:0018022 | peptidyl-lysine methylation | 10.49% (15/143) | 3.64 | 0.0 | 0.0 |
| GO:0034968 | histone lysine methylation | 10.49% (15/143) | 3.65 | 0.0 | 0.0 |
| GO:0046483 | heterocycle metabolic process | 32.87% (47/143) | 1.59 | 0.0 | 0.0 |
| GO:0045814 | negative regulation of gene expression, epigenetic | 10.49% (15/143) | 3.6 | 0.0 | 0.0 |
| GO:0016571 | histone methylation | 11.19% (16/143) | 3.44 | 0.0 | 0.0 |
| GO:0034641 | cellular nitrogen compound metabolic process | 33.57% (48/143) | 1.53 | 0.0 | 0.0 |
| GO:0006325 | chromatin organization | 13.99% (20/143) | 2.87 | 0.0 | 0.0 |
| GO:0022402 | cell cycle process | 13.99% (20/143) | 2.83 | 0.0 | 0.0 |
| GO:0010605 | negative regulation of macromolecule metabolic process | 14.69% (21/143) | 2.7 | 0.0 | 0.0 |
| GO:0040029 | regulation of gene expression, epigenetic | 10.49% (15/143) | 3.38 | 0.0 | 0.0 |
| GO:0032259 | methylation | 13.29% (19/143) | 2.84 | 0.0 | 0.0 |
| GO:0043414 | macromolecule methylation | 13.29% (19/143) | 2.84 | 0.0 | 0.0 |
| GO:0006342 | chromatin silencing | 9.79% (14/143) | 3.52 | 0.0 | 0.0 |
| GO:0009892 | negative regulation of metabolic process | 14.69% (21/143) | 2.63 | 0.0 | 0.0 |
| GO:0010558 | negative regulation of macromolecule biosynthetic process | 11.89% (17/143) | 3.04 | 0.0 | 0.0 |
| GO:2000113 | negative regulation of cellular macromolecule biosynthetic process | 11.89% (17/143) | 3.04 | 0.0 | 0.0 |
| GO:0045934 | negative regulation of nucleobase-containing compound metabolic process | 11.89% (17/143) | 3.03 | 0.0 | 0.0 |
| GO:0051172 | negative regulation of nitrogen compound metabolic process | 12.59% (18/143) | 2.89 | 0.0 | 0.0 |
| GO:0006725 | cellular aromatic compound metabolic process | 32.87% (47/143) | 1.45 | 0.0 | 0.0 |
| GO:0051052 | regulation of DNA metabolic process | 9.09% (13/143) | 3.63 | 0.0 | 0.0 |
| GO:0031327 | negative regulation of cellular biosynthetic process | 11.89% (17/143) | 3.01 | 0.0 | 0.0 |
| GO:0009890 | negative regulation of biosynthetic process | 11.89% (17/143) | 2.99 | 0.0 | 0.0 |
| GO:0005634 | nucleus | 60.14% (86/143) | 0.84 | 0.0 | 0.0 |
| GO:0010629 | negative regulation of gene expression | 13.29% (19/143) | 2.73 | 0.0 | 0.0 |
| GO:0031324 | negative regulation of cellular metabolic process | 12.59% (18/143) | 2.83 | 0.0 | 0.0 |
| GO:0045892 | negative regulation of transcription, DNA-templated | 11.19% (16/143) | 3.01 | 0.0 | 0.0 |
| GO:1902679 | negative regulation of RNA biosynthetic process | 11.19% (16/143) | 3.01 | 0.0 | 0.0 |
| GO:1903507 | negative regulation of nucleic acid-templated transcription | 11.19% (16/143) | 3.01 | 0.0 | 0.0 |
| GO:0051253 | negative regulation of RNA metabolic process | 11.19% (16/143) | 2.99 | 0.0 | 0.0 |
| GO:1901360 | organic cyclic compound metabolic process | 32.87% (47/143) | 1.38 | 0.0 | 0.0 |
| GO:0018205 | peptidyl-lysine modification | 10.49% (15/143) | 3.09 | 0.0 | 0.0 |
| GO:0006275 | regulation of DNA replication | 6.99% (10/143) | 3.85 | 0.0 | 0.0 |
| GO:0018193 | peptidyl-amino acid modification | 10.49% (15/143) | 2.85 | 0.0 | 0.0 |
| GO:0044260 | cellular macromolecule metabolic process | 32.17% (46/143) | 1.3 | 0.0 | 0.0 |
| GO:0044424 | intracellular part | 90.21% (129/143) | 0.36 | 0.0 | 0.0 |
| GO:0048523 | negative regulation of cellular process | 13.29% (19/143) | 2.29 | 0.0 | 0.0 |
| GO:1903047 | mitotic cell cycle process | 7.69% (11/143) | 3.25 | 0.0 | 1e-06 |
| GO:0031047 | gene silencing by RNA | 7.69% (11/143) | 3.23 | 0.0 | 1e-06 |
| GO:0034645 | cellular macromolecule biosynthetic process | 16.78% (24/143) | 1.86 | 0.0 | 1e-06 |
| GO:0000911 | cytokinesis by cell plate formation | 6.99% (10/143) | 3.37 | 0.0 | 1e-06 |
| GO:0032506 | cytokinetic process | 6.99% (10/143) | 3.34 | 0.0 | 1e-06 |
| GO:1902410 | mitotic cytokinetic process | 6.99% (10/143) | 3.34 | 0.0 | 1e-06 |
| GO:0031048 | chromatin silencing by small RNA | 5.59% (8/143) | 3.75 | 0.0 | 3e-06 |
| GO:0008283 | cell proliferation | 6.29% (9/143) | 3.43 | 0.0 | 3e-06 |
| GO:0006346 | methylation-dependent chromatin silencing | 5.59% (8/143) | 3.73 | 0.0 | 3e-06 |
| GO:0048519 | negative regulation of biological process | 15.38% (22/143) | 1.84 | 0.0 | 3e-06 |
| GO:0043170 | macromolecule metabolic process | 34.27% (49/143) | 1.01 | 0.0 | 7e-06 |
| GO:0009059 | macromolecule biosynthetic process | 16.78% (24/143) | 1.67 | 0.0 | 8e-06 |
| GO:0044427 | chromosomal part | 4.9% (7/143) | 3.88 | 1e-06 | 9e-06 |
| GO:0016572 | histone phosphorylation | 4.2% (6/143) | 4.23 | 1e-06 | 1.4e-05 |
| GO:0043229 | intracellular organelle | 79.72% (114/143) | 0.39 | 1e-06 | 1.5e-05 |
| GO:0043226 | organelle | 79.72% (114/143) | 0.39 | 1e-06 | 1.5e-05 |
| GO:0010389 | regulation of G2/M transition of mitotic cell cycle | 4.2% (6/143) | 4.18 | 1e-06 | 1.5e-05 |
| GO:1902749 | regulation of cell cycle G2/M phase transition | 4.2% (6/143) | 4.18 | 1e-06 | 1.5e-05 |
| GO:0043231 | intracellular membrane-bounded organelle | 79.02% (113/143) | 0.4 | 1e-06 | 1.5e-05 |
| GO:0007346 | regulation of mitotic cell cycle | 4.9% (7/143) | 3.72 | 1e-06 | 1.6e-05 |
| GO:0006270 | DNA replication initiation | 4.2% (6/143) | 4.16 | 1e-06 | 1.6e-05 |
| GO:0043227 | membrane-bounded organelle | 79.02% (113/143) | 0.4 | 1e-06 | 1.6e-05 |
| GO:0006807 | nitrogen compound metabolic process | 36.36% (52/143) | 0.91 | 1e-06 | 2e-05 |
| GO:1901987 | regulation of cell cycle phase transition | 4.2% (6/143) | 4.09 | 1e-06 | 2e-05 |
| GO:1901990 | regulation of mitotic cell cycle phase transition | 4.2% (6/143) | 4.09 | 1e-06 | 2e-05 |
| GO:0042023 | DNA endoreduplication | 4.9% (7/143) | 3.61 | 2e-06 | 2.5e-05 |
| GO:0044786 | cell cycle DNA replication | 4.9% (7/143) | 3.6 | 2e-06 | 2.6e-05 |
| GO:0006974 | cellular response to DNA damage stimulus | 6.99% (10/143) | 2.71 | 3e-06 | 4.5e-05 |
| GO:0000226 | microtubule cytoskeleton organization | 6.29% (9/143) | 2.86 | 5e-06 | 6.1e-05 |
| GO:0044464 | cell part | 91.61% (131/143) | 0.25 | 5e-06 | 6.1e-05 |
| GO:0006281 | DNA repair | 6.29% (9/143) | 2.81 | 6e-06 | 8e-05 |
| GO:0010564 | regulation of cell cycle process | 4.9% (7/143) | 3.28 | 8e-06 | 0.000104 |
| GO:0048449 | floral organ formation | 4.9% (7/143) | 3.27 | 9e-06 | 0.000106 |
| GO:0007017 | microtubule-based process | 6.29% (9/143) | 2.75 | 9e-06 | 0.000108 |
| GO:0006302 | double-strand break repair | 4.2% (6/143) | 3.48 | 1.7e-05 | 0.000209 |
| GO:0000280 | nuclear division | 3.5% (5/143) | 3.94 | 1.9e-05 | 0.000229 |
| GO:0004693 | cyclin-dependent protein serine/threonine kinase activity | 2.8% (4/143) | 4.6 | 2.2e-05 | 0.000259 |
| GO:0097472 | cyclin-dependent protein kinase activity | 2.8% (4/143) | 4.6 | 2.2e-05 | 0.000259 |
| GO:0060255 | regulation of macromolecule metabolic process | 19.58% (28/143) | 1.18 | 3.5e-05 | 0.000409 |
| GO:0006305 | DNA alkylation | 4.9% (7/143) | 2.91 | 4.4e-05 | 0.000497 |
| GO:0006306 | DNA methylation | 4.9% (7/143) | 2.91 | 4.4e-05 | 0.000497 |
| GO:0044728 | DNA methylation or demethylation | 4.9% (7/143) | 2.89 | 4.7e-05 | 0.000527 |
| GO:0006464 | cellular protein modification process | 15.38% (22/143) | 1.35 | 4.9e-05 | 0.000531 |
| GO:0036211 | protein modification process | 15.38% (22/143) | 1.35 | 4.9e-05 | 0.000531 |
| GO:0006304 | DNA modification | 4.9% (7/143) | 2.89 | 4.9e-05 | 0.000539 |
| GO:0019219 | regulation of nucleobase-containing compound metabolic process | 17.48% (25/143) | 1.21 | 6.8e-05 | 0.000733 |
| GO:1905393 | plant organ formation | 4.9% (7/143) | 2.8 | 7e-05 | 0.000747 |
| GO:0051225 | spindle assembly | 2.8% (4/143) | 4.07 | 9.4e-05 | 0.000995 |
| GO:0051171 | regulation of nitrogen compound metabolic process | 18.18% (26/143) | 1.15 | 9.7e-05 | 0.001009 |
| GO:0033044 | regulation of chromosome organization | 4.2% (6/143) | 3.03 | 9.9e-05 | 0.001021 |
| GO:0009909 | regulation of flower development | 6.29% (9/143) | 2.28 | 0.00011 | 0.001122 |
| GO:0007051 | spindle organization | 2.8% (4/143) | 4.01 | 0.000112 | 0.001131 |
| GO:0006996 | organelle organization | 12.59% (18/143) | 1.44 | 0.000114 | 0.001147 |
| GO:0070925 | organelle assembly | 2.8% (4/143) | 3.98 | 0.000121 | 0.001203 |
| GO:0007010 | cytoskeleton organization | 6.29% (9/143) | 2.25 | 0.000124 | 0.001211 |
| GO:0010212 | response to ionizing radiation | 3.5% (5/143) | 3.38 | 0.000124 | 0.001221 |
| GO:0043412 | macromolecule modification | 16.78% (24/143) | 1.18 | 0.000127 | 0.001228 |
| GO:0048285 | organelle fission | 3.5% (5/143) | 3.35 | 0.000137 | 0.001312 |
| GO:0010556 | regulation of macromolecule biosynthetic process | 16.78% (24/143) | 1.15 | 0.000175 | 0.001637 |
| GO:2000112 | regulation of cellular macromolecule biosynthetic process | 16.78% (24/143) | 1.15 | 0.000175 | 0.001637 |
| GO:0016043 | cellular component organization | 20.28% (29/143) | 1.01 | 0.000189 | 0.001754 |
| GO:0051276 | chromosome organization | 4.9% (7/143) | 2.56 | 0.000196 | 0.001807 |
| GO:0048831 | regulation of shoot system development | 6.29% (9/143) | 2.14 | 0.00022 | 0.002006 |
| GO:0048580 | regulation of post-embryonic development | 6.99% (10/143) | 2.0 | 0.000224 | 0.00203 |
| GO:0006310 | DNA recombination | 4.9% (7/143) | 2.51 | 0.000242 | 0.002169 |
| GO:0031326 | regulation of cellular biosynthetic process | 16.78% (24/143) | 1.12 | 0.000245 | 0.002179 |
| GO:0080090 | regulation of primary metabolic process | 18.18% (26/143) | 1.06 | 0.000258 | 0.002275 |
| GO:0050794 | regulation of cellular process | 25.87% (37/143) | 0.83 | 0.000265 | 0.002319 |
| GO:1903046 | meiotic cell cycle process | 4.9% (7/143) | 2.48 | 0.000282 | 0.002438 |
| GO:0031323 | regulation of cellular metabolic process | 18.18% (26/143) | 1.04 | 0.000313 | 0.002687 |
| GO:0019222 | regulation of metabolic process | 19.58% (28/143) | 0.99 | 0.000327 | 0.002783 |
| GO:0044267 | cellular protein metabolic process | 16.08% (23/143) | 1.11 | 0.00039 | 0.003295 |
| GO:2000241 | regulation of reproductive process | 6.29% (9/143) | 2.02 | 0.000402 | 0.003372 |
| GO:0016246 | RNA interference | 2.8% (4/143) | 3.51 | 0.000432 | 0.003588 |
| GO:0044237 | cellular metabolic process | 38.46% (55/143) | 0.59 | 0.000459 | 0.003787 |
| GO:0022414 | reproductive process | 16.78% (24/143) | 1.06 | 0.000469 | 0.003834 |
| GO:0009889 | regulation of biosynthetic process | 16.78% (24/143) | 1.05 | 0.000503 | 0.004082 |
| GO:0000808 | origin recognition complex | 1.4% (2/143) | 5.79 | 0.000548 | 0.004244 |
| GO:0009292 | genetic transfer | 2.1% (3/143) | 4.23 | 0.000547 | 0.004269 |
| GO:0009294 | DNA mediated transformation | 2.1% (3/143) | 4.23 | 0.000547 | 0.004269 |
| GO:0044764 | multi-organism cellular process | 2.1% (3/143) | 4.23 | 0.000547 | 0.004269 |
| GO:0048451 | petal formation | 2.8% (4/143) | 3.43 | 0.000537 | 0.004286 |
| GO:0048453 | sepal formation | 2.8% (4/143) | 3.43 | 0.000537 | 0.004286 |
| GO:2000026 | regulation of multicellular organismal development | 6.99% (10/143) | 1.82 | 0.000569 | 0.004369 |
| GO:0051128 | regulation of cellular component organization | 5.59% (8/143) | 2.11 | 0.00058 | 0.004426 |
| GO:0005515 | protein binding | 16.08% (23/143) | 1.06 | 0.000628 | 0.00472 |
| GO:0010332 | response to gamma radiation | 2.8% (4/143) | 3.37 | 0.000627 | 0.004744 |
| GO:0071840 | cellular component organization or biogenesis | 20.28% (29/143) | 0.9 | 0.000643 | 0.004764 |
| GO:0050789 | regulation of biological process | 27.97% (40/143) | 0.73 | 0.00064 | 0.004773 |
| GO:0044238 | primary metabolic process | 35.66% (51/143) | 0.6 | 0.000657 | 0.00483 |
| GO:0008094 | DNA-dependent ATPase activity | 2.1% (3/143) | 4.09 | 0.00072 | 0.005258 |
| GO:0035194 | posttranscriptional gene silencing by RNA | 2.8% (4/143) | 3.31 | 0.000727 | 0.005268 |
| GO:0051239 | regulation of multicellular organismal process | 6.99% (10/143) | 1.76 | 0.000812 | 0.005841 |
| GO:0048646 | anatomical structure formation involved in morphogenesis | 4.9% (7/143) | 2.15 | 0.00106 | 0.007573 |
| GO:0016441 | posttranscriptional gene silencing | 2.8% (4/143) | 3.15 | 0.001094 | 0.007765 |
| GO:2001252 | positive regulation of chromosome organization | 1.4% (2/143) | 5.14 | 0.001416 | 0.009983 |
| GO:0140096 | catalytic activity, acting on a protein | 11.89% (17/143) | 1.17 | 0.001515 | 0.010607 |
| GO:0000278 | mitotic cell cycle | 3.5% (5/143) | 2.58 | 0.001572 | 0.010931 |
| GO:0061982 | meiosis I cell cycle process | 2.8% (4/143) | 2.92 | 0.001968 | 0.013589 |
| GO:0006349 | regulation of gene expression by genetic imprinting | 1.4% (2/143) | 4.89 | 0.001995 | 0.013593 |
| GO:0071514 | genetic imprinting | 1.4% (2/143) | 4.89 | 0.001995 | 0.013593 |
| GO:0033043 | regulation of organelle organization | 4.2% (6/143) | 2.2 | 0.002039 | 0.013708 |
| GO:0050793 | regulation of developmental process | 8.39% (12/143) | 1.41 | 0.002035 | 0.01377 |
| GO:1990234 | transferase complex | 4.2% (6/143) | 2.19 | 0.002121 | 0.014168 |
| GO:0010468 | regulation of gene expression | 15.38% (22/143) | 0.95 | 0.002207 | 0.014551 |
| GO:0071704 | organic substance metabolic process | 37.76% (54/143) | 0.51 | 0.002205 | 0.014635 |
| GO:0004674 | protein serine/threonine kinase activity | 4.9% (7/143) | 1.96 | 0.002284 | 0.014965 |
| GO:0045132 | meiotic chromosome segregation | 2.8% (4/143) | 2.84 | 0.002423 | 0.015775 |
| GO:0098813 | nuclear chromosome segregation | 2.8% (4/143) | 2.83 | 0.002506 | 0.016207 |
| GO:0009957 | epidermal cell fate specification | 1.4% (2/143) | 4.69 | 0.002668 | 0.017146 |
| GO:0006355 | regulation of transcription, DNA-templated | 13.99% (20/143) | 0.98 | 0.002814 | 0.01775 |
| GO:1903506 | regulation of nucleic acid-templated transcription | 13.99% (20/143) | 0.98 | 0.002814 | 0.01775 |
| GO:2001141 | regulation of RNA biosynthetic process | 13.99% (20/143) | 0.98 | 0.002814 | 0.01775 |
| GO:0008152 | metabolic process | 39.86% (57/143) | 0.47 | 0.002875 | 0.018025 |
| GO:0001708 | cell fate specification | 2.1% (3/143) | 3.37 | 0.003071 | 0.019023 |
| GO:0051252 | regulation of RNA metabolic process | 13.99% (20/143) | 0.96 | 0.003068 | 0.019119 |
| GO:0006312 | mitotic recombination | 2.1% (3/143) | 3.35 | 0.00323 | 0.019884 |
| GO:0019538 | protein metabolic process | 17.48% (25/143) | 0.8 | 0.004138 | 0.025326 |
| GO:0007140 | male meiotic nuclear division | 1.4% (2/143) | 4.35 | 0.004286 | 0.025918 |
| GO:0140013 | meiotic nuclear division | 1.4% (2/143) | 4.35 | 0.004286 | 0.025918 |
| GO:0060089 | molecular transducer activity | 2.8% (4/143) | 2.6 | 0.004456 | 0.026634 |
| GO:0007059 | chromosome segregation | 2.8% (4/143) | 2.6 | 0.004456 | 0.026634 |
| GO:0008618 | 7-methylguanosine metabolic process | 0.7% (1/143) | 7.6 | 0.005171 | 0.02724 |
| GO:0000012 | single strand break repair | 0.7% (1/143) | 7.6 | 0.005171 | 0.02724 |
| GO:0000087 | mitotic M phase | 0.7% (1/143) | 7.6 | 0.005171 | 0.02724 |
| GO:0000279 | M phase | 0.7% (1/143) | 7.6 | 0.005171 | 0.02724 |
| GO:0098763 | mitotic cell cycle phase | 0.7% (1/143) | 7.6 | 0.005171 | 0.02724 |
| GO:0015231 | 5-formyltetrahydrofolate transmembrane transporter activity | 0.7% (1/143) | 7.6 | 0.005171 | 0.02724 |
| GO:0015350 | methotrexate transmembrane transporter activity | 0.7% (1/143) | 7.6 | 0.005171 | 0.02724 |
| GO:0051958 | methotrexate transport | 0.7% (1/143) | 7.6 | 0.005171 | 0.02724 |
| GO:0003688 | DNA replication origin binding | 0.7% (1/143) | 7.6 | 0.005171 | 0.02724 |
| GO:0035404 | histone-serine phosphorylation | 0.7% (1/143) | 7.6 | 0.005171 | 0.02724 |
| GO:0043987 | histone H3-S10 phosphorylation | 0.7% (1/143) | 7.6 | 0.005171 | 0.02724 |
| GO:0043988 | histone H3-S28 phosphorylation | 0.7% (1/143) | 7.6 | 0.005171 | 0.02724 |
| GO:0044022 | histone kinase activity (H3-S28 specific) | 0.7% (1/143) | 7.6 | 0.005171 | 0.02724 |
| GO:0006887 | exocytosis | 0.7% (1/143) | 7.6 | 0.005171 | 0.02724 |
| GO:0007063 | regulation of sister chromatid cohesion | 0.7% (1/143) | 7.6 | 0.005171 | 0.02724 |
| GO:0032878 | regulation of establishment or maintenance of cell polarity | 0.7% (1/143) | 7.6 | 0.005171 | 0.02724 |
| GO:0045876 | positive regulation of sister chromatid cohesion | 0.7% (1/143) | 7.6 | 0.005171 | 0.02724 |
| GO:0051984 | positive regulation of chromosome segregation | 0.7% (1/143) | 7.6 | 0.005171 | 0.02724 |
| GO:2000114 | regulation of establishment of cell polarity | 0.7% (1/143) | 7.6 | 0.005171 | 0.02724 |
| GO:0032981 | mitochondrial respiratory chain complex I assembly | 0.7% (1/143) | 7.6 | 0.005171 | 0.02724 |
| GO:0032196 | transposition | 0.7% (1/143) | 7.6 | 0.005171 | 0.02724 |
| GO:0032197 | transposition, RNA-mediated | 0.7% (1/143) | 7.6 | 0.005171 | 0.02724 |
| GO:0090241 | negative regulation of histone H4 acetylation | 0.7% (1/143) | 7.6 | 0.005171 | 0.02724 |
| GO:0003713 | transcription coactivator activity | 1.4% (2/143) | 4.2 | 0.005228 | 0.027399 |
| GO:0007131 | reciprocal meiotic recombination | 2.8% (4/143) | 2.51 | 0.005518 | 0.028773 |
| GO:0035825 | homologous recombination | 2.8% (4/143) | 2.5 | 0.005662 | 0.029372 |
| GO:0007049 | cell cycle | 3.5% (5/143) | 2.14 | 0.005715 | 0.029498 |
| GO:0065007 | biological regulation | 28.67% (41/143) | 0.55 | 0.005787 | 0.029718 |
| GO:0044249 | cellular biosynthetic process | 20.98% (30/143) | 0.67 | 0.006035 | 0.030839 |
| GO:0007062 | sister chromatid cohesion | 2.8% (4/143) | 2.46 | 0.006261 | 0.031833 |
| GO:0007129 | synapsis | 2.1% (3/143) | 2.86 | 0.00832 | 0.042095 |
| GO:0005640 | nuclear outer membrane | 0.7% (1/143) | 6.6 | 0.010315 | 0.045052 |
| GO:0006271 | DNA strand elongation involved in DNA replication | 0.7% (1/143) | 6.6 | 0.010315 | 0.045052 |
| GO:0022616 | DNA strand elongation | 0.7% (1/143) | 6.6 | 0.010315 | 0.045052 |
| GO:0004146 | dihydrofolate reductase activity | 0.7% (1/143) | 6.6 | 0.010315 | 0.045052 |
| GO:0004799 | thymidylate synthase activity | 0.7% (1/143) | 6.6 | 0.010315 | 0.045052 |
| GO:0009256 | 10-formyltetrahydrofolate metabolic process | 0.7% (1/143) | 6.6 | 0.010315 | 0.045052 |
| GO:0009257 | 10-formyltetrahydrofolate biosynthetic process | 0.7% (1/143) | 6.6 | 0.010315 | 0.045052 |
| GO:0042083 | 5,10-methylenetetrahydrofolate-dependent methyltransferase activity | 0.7% (1/143) | 6.6 | 0.010315 | 0.045052 |
| GO:0052381 | tRNA dimethylallyltransferase activity | 0.7% (1/143) | 6.6 | 0.010315 | 0.045052 |
| GO:0070182 | DNA polymerase binding | 0.7% (1/143) | 6.6 | 0.010315 | 0.045052 |
| GO:0000307 | cyclin-dependent protein kinase holoenzyme complex | 0.7% (1/143) | 6.6 | 0.010315 | 0.045052 |
| GO:0018105 | peptidyl-serine phosphorylation | 0.7% (1/143) | 6.6 | 0.010315 | 0.045052 |
| GO:0018209 | peptidyl-serine modification | 0.7% (1/143) | 6.6 | 0.010315 | 0.045052 |
| GO:0009186 | deoxyribonucleoside diphosphate metabolic process | 0.7% (1/143) | 6.6 | 0.010315 | 0.045052 |
| GO:0000706 | meiotic DNA double-strand break processing | 0.7% (1/143) | 6.6 | 0.010315 | 0.045052 |
| GO:0000729 | DNA double-strand break processing | 0.7% (1/143) | 6.6 | 0.010315 | 0.045052 |
| GO:0000798 | nuclear cohesin complex | 0.7% (1/143) | 6.6 | 0.010315 | 0.045052 |
| GO:0051304 | chromosome separation | 0.7% (1/143) | 6.6 | 0.010315 | 0.045052 |
| GO:0051307 | meiotic chromosome separation | 0.7% (1/143) | 6.6 | 0.010315 | 0.045052 |
| GO:0003880 | protein C-terminal carboxyl O-methyltransferase activity | 0.7% (1/143) | 6.6 | 0.010315 | 0.045052 |
| GO:0004671 | protein C-terminal S-isoprenylcysteine carboxyl O-methyltransferase activity | 0.7% (1/143) | 6.6 | 0.010315 | 0.045052 |
| GO:0006481 | C-terminal protein methylation | 0.7% (1/143) | 6.6 | 0.010315 | 0.045052 |
| GO:0018410 | C-terminal protein amino acid modification | 0.7% (1/143) | 6.6 | 0.010315 | 0.045052 |
| GO:0035102 | PRC1 complex | 0.7% (1/143) | 6.6 | 0.010315 | 0.045052 |
| GO:0000281 | mitotic cytokinesis | 0.7% (1/143) | 6.6 | 0.010315 | 0.045052 |
| GO:0010069 | zygote asymmetric cytokinesis in embryo sac | 0.7% (1/143) | 6.6 | 0.010315 | 0.045052 |
| GO:0033108 | mitochondrial respiratory chain complex assembly | 0.7% (1/143) | 6.6 | 0.010315 | 0.045052 |
| GO:0006344 | maintenance of chromatin silencing | 0.7% (1/143) | 6.6 | 0.010315 | 0.045052 |
| GO:0090239 | regulation of histone H4 acetylation | 0.7% (1/143) | 6.6 | 0.010315 | 0.045052 |
| GO:0003712 | transcription coregulator activity | 1.4% (2/143) | 3.69 | 0.010505 | 0.045686 |
| GO:0070192 | chromosome organization involved in meiotic cell cycle | 2.1% (3/143) | 2.81 | 0.009201 | 0.046094 |
| GO:0045787 | positive regulation of cell cycle | 1.4% (2/143) | 3.79 | 0.00919 | 0.046268 |
| GO:0010608 | posttranscriptional regulation of gene expression | 2.8% (4/143) | 2.27 | 0.009681 | 0.048266 |
| GO:0140097 | catalytic activity, acting on DNA | 2.1% (3/143) | 2.69 | 0.011461 | 0.049633 |